Veritas In Silico (TSE:130A) Other Current Liabilities: 円58.21 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:130A Veritas In Silico Inc TSE:130A
13 GF Score
Price 円403.00
! 4 Warning Signs
View Full Analysis

What is Veritas In Silico Other Current Liabilities?

Veritas In Silico TSE:130A -2.42% 13 Other Current Liabilities is 円58.21 Mil as of Dec. 2025. GuruFocus rates TSE:130A with a GF Score™ of 13/100. The stock has 4 warning signs investors should review.

Veritas In Silico's other current liabilities for the quarter that ended in Dec. 2025 was 円58.21 Mil.

Veritas In Silico's quarterly other current liabilities declined from Jun. 2025 (円20.06 Mil) to Sep. 2025 (円11.36 Mil) but then increased from Sep. 2025 (円11.36 Mil) to Dec. 2025 (円58.21 Mil).

Veritas In Silico's annual other current liabilities declined from Dec. 2023 (円52.58 Mil) to Dec. 2024 (円2.90 Mil) but then increased from Dec. 2024 (円2.90 Mil) to Dec. 2025 (円58.21 Mil).

Veritas In Silico Other Current Liabilities Related Terms

Veritas In Silico Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Veritas In Silico's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veritas In Silico Other Current Liabilities Chart

Veritas In Silico Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
27.11 28.96 52.58 2.90 58.21

Veritas In Silico Quarterly Data
Dec21 Dec22 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.87 20.06 11.36 58.21 71.95
TSE:130A
13GF Score
Veritas In Silico Inc TSE:130A
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Veritas In Silico Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of 円58.21 Mil mean?
Veritas In Silico (TSE:130A) has a Other Current Liabilities of 円58.21 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Veritas In Silico.
Is Veritas In Silico's Other Current Liabilities too high?
Veritas In Silico's current Other Current Liabilities is 円58.21 Mil. Overall, Veritas In Silico has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Veritas In Silico's Other Current Liabilities compare to VRTX and REGN?
Veritas In Silico's Other Current Liabilities of 円58.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Veritas In Silico. Veritas In Silico's current Other Current Liabilities is 円58.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veritas In Silico stock overvalued right now?
Veritas In Silico (TSE:130A) has a current Other Current Liabilities of 円58.21 Mil. The current Other Current Liabilities is 円58.21 Mil. Veritas In Silico's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Veritas In Silico (TSE:130A), the current Other Current Liabilities is 円58.21 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Veritas In Silico Business Description

Address 1-11-1, Nishigotanda, Shinagawa-ku, Tokyo, JPN, 141-0031
Veritas In Silico Inc is engaged in discovery of mRNA-targeted small molecule and antisense oligonucleotide drugs. It has ibVIS platform that combines informatics (i) and experimental biology at Veritas In Silico (VIS) that will bring to fruition mRNA-targeted drugs.
13GF Score

Get the complete analysis for TSE:130A

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円403.00
Price